Free Trial

Cogent Biosciences (COGT) News Today

$8.98
-0.52 (-5.47%)
(As of 07/17/2024 ET)
Contrasting Cogent Biosciences (NASDAQ:COGT) & Arvinas (NASDAQ:ARVN)
Cogent Biosciences logo with Medical background
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 4.9%
Cogent Biosciences (NASDAQ:COGT) Trading Down 4.9%
Cogent Biosciences logo with Medical background
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Brokerages
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and five have issued a buy
Cogent Biosciences logo with Medical background
Cogent Biosciences (NASDAQ:COGT) Shares Up 5.6%
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 5.6%
Cogent Biosciences logo with Medical background
Needham & Company LLC Reaffirms Buy Rating for Cogent Biosciences (NASDAQ:COGT)
Needham & Company LLC reissued a "buy" rating and set a $18.00 price objective on shares of Cogent Biosciences in a research note on Thursday.
Cogent Biosciences logo with Medical background
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 5.3%
Cogent Biosciences (NASDAQ:COGT) Trading Down 5.3%
Cogent Biosciences: Inflection Year Directly Ahead
Cogent Biosciences logo with Medical background
Cogent Biosciences (NASDAQ:COGT) Shares Up 5.1%
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 5.1%
Cogent Biosciences logo with Medical background
Cogent Biosciences, Inc. (NASDAQ:COGT) Short Interest Update
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) saw a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 14,400,000 shares, an increase of 7.0% from the May 15th total of 13,460,000 shares. Based on an average trading volume of 1,400,000 shares, the short-interest ratio is presently 10.3 days.
Cogent Biosciences logo with Medical background
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 6.5%
Cogent Biosciences (NASDAQ:COGT) Shares Down 6.5%
Cogent Biosciences logo with Medical background
Cogent Biosciences' (COGT) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reaffirmed a "buy" rating and set a $18.00 price objective on shares of Cogent Biosciences in a research report on Monday.
Cogent Biosciences, Inc. (NASDAQ:COGT) Stake Trimmed by Perceptive Advisors LLC
Perceptive Advisors LLC cut its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 51.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,122,958 shares of the technology compan
Frazier Life Sciences Management L.P. Has $11.73 Million Position in Cogent Biosciences, Inc. (NASDAQ:COGT)
Frazier Life Sciences Management L.P. lifted its stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 32.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,995,267 shares of the technology company's stock a
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Acquired by Rafferty Asset Management LLC
Rafferty Asset Management LLC grew its holdings in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 50.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 288,671 shares of the technology company's stock after acq
Cogent Biosciences, Inc. (NASDAQ:COGT) is Kynam Capital Management LP's 9th Largest Position
Kynam Capital Management LP grew its stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 164.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,854,766 shares of the technology company's stock after
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 5.4%
Cogent Biosciences (NASDAQ:COGT) Trading Down 5.4%
New Leaf Venture Partners L.L.C. Sells 250,765 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
New Leaf Venture Partners L.L.C. reduced its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 50.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 250,765 shares of the technology company's
Short Interest in Cogent Biosciences, Inc. (NASDAQ:COGT) Grows By 11.8%
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 13,460,000 shares, an increase of 11.8% from the April 30th total of 12,040,000 shares. Based on an average daily volume of 1,550,000 shares, the days-to-cover ratio is presently 8.7 days.
Cogent Biosciences (NASDAQ:COGT) Trading Up 5.5%
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 5.5%
Cogent Biosciences (NASDAQ:COGT) Trading Down 6.1%
Cogent Biosciences (NASDAQ:COGT) Shares Down 6.1%
Cogent Biosciences (NASDAQ:COGT) Given Neutral Rating at Wedbush
Wedbush reissued a "neutral" rating and issued a $10.00 price objective on shares of Cogent Biosciences in a research report on Friday.
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 6.4%
Cogent Biosciences (NASDAQ:COGT) Trading Down 6.4%
Cogent Biosciences Inc (COGT)
Q2 2024 Earnings Forecast for Cogent Biosciences, Inc. Issued By HC Wainwright (NASDAQ:COGT)
Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Analysts at HC Wainwright lowered their Q2 2024 earnings per share (EPS) estimates for shares of Cogent Biosciences in a note issued to investors on Monday, May 13th. HC Wainwright analyst R. Burns now anticipates that the technology company
Cogent Biosciences (NASDAQ:COGT) Earns "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $19.00 price target on shares of Cogent Biosciences in a research report on Monday.
Q2 2024 Earnings Estimate for Cogent Biosciences, Inc. Issued By Leerink Partnrs (NASDAQ:COGT)
Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Equities researchers at Leerink Partnrs lowered their Q2 2024 earnings estimates for Cogent Biosciences in a report issued on Tuesday, May 7th. Leerink Partnrs analyst A. Berens now forecasts that the technology company will post earnings per
Cogent Biosciences (NASDAQ:COGT) Earns Buy Rating from Needham & Company LLC
Needham & Company LLC restated a "buy" rating and set a $18.00 price objective on shares of Cogent Biosciences in a research note on Wednesday.
Cogent Biosciences (NASDAQ:COGT) Issues Quarterly Earnings Results, Misses Expectations By $0.11 EPS
Cogent Biosciences (NASDAQ:COGT - Get Free Report) released its quarterly earnings data on Tuesday. The technology company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.51) by ($0.11).
Short Interest in Cogent Biosciences, Inc. (NASDAQ:COGT) Rises By 15.0%
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 12,470,000 shares, a growth of 15.0% from the March 31st total of 10,840,000 shares. Based on an average trading volume of 2,100,000 shares, the short-interest ratio is presently 5.9 days.
Cogent Biosciences (NASDAQ:COGT) Shares Up 11.5%
Cogent Biosciences (NASDAQ:COGT) Trading 11.5% Higher
Cogent Biosciences (NASDAQ:COGT) Trading Down 8.3%
Cogent Biosciences (NASDAQ:COGT) Trading Down 8.3%
Cogent Biosciences (NASDAQ:COGT) Shares Up 4%
Cogent Biosciences (NASDAQ:COGT) Trading Up 4%
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Rating of "Moderate Buy" from Analysts
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The av
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 7.3%
Cogent Biosciences (NASDAQ:COGT) Trading Down 7.3%
Cogent Biosciences (NASDAQ:COGT) Shares Up 6.3%
Cogent Biosciences (NASDAQ:COGT) Shares Up 6.3%
Cogent Biosciences (NASDAQ:COGT) Trading Down 8%
Cogent Biosciences (NASDAQ:COGT) Shares Down 8%
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Acquired by SG Americas Securities LLC
SG Americas Securities LLC grew its stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 203.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 317,409 shares of the technology company's stock
Cogent Biosciences (NASDAQ:COGT) Trading 10.4% Higher
Cogent Biosciences (NASDAQ:COGT) Shares Up 10.4%
Cogent Biosciences (NASDAQ:COGT) Trading Down 5.2%
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 5.2%
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have
Get Cogent Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter.

Could You Retire on a Single AI Stock (trading for only $15)? (Ad)

This is the perfect AI stock...And it's currently trading for only $15. With just one investment in this company, you could potentially set yourself up for massive financial gains.

Click here for the ticker >>>

COGT Media Mentions By Week

COGT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

COGT
News Sentiment

1.18

0.93

Average
Medical
News Sentiment

COGT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

COGT Articles
This Week

4

2

COGT Articles
Average Week

Get Cogent Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:COGT) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners